Ghada E Elgarawany
Overview
Explore the profile of Ghada E Elgarawany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elgarawany G, Shevade S, Aldebi S, Ahmed B, Omer F, Adel R
Cureus
. 2024 Jul;
16(6):e61773.
PMID: 38975396
Background and objective COVID-19 is a respiratory disease that is highly contagious and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms vary from mild to severe, where...
2.
Elgarawany G, Badawy A, Hazzaa S
Arch Physiol Biochem
. 2020 Jul;
129(1):108-115.
PMID: 32718232
Oxidative stress is the main player in the development of diabetic vascular complications. Co-Q10 is a natural antioxidant present in the body and in many foods. This study was designed...
3.
Hazzaa S, Ahmed Mohamed Abdelaziz S, Abd Eldaim M, Abdel-Daim M, Elgarawany G
Nutrients
. 2020 Apr;
12(4).
PMID: 32290031
This study evaluated the neuroprotective potential of against monosodium glutamate (MSG)-induced neurotoxicity with respect to its impact on short-term memory in rats. Forty male Wistar albino rats were assigned into...
4.
Hazzaa S, El-Roghy E, Abd Eldaim M, Elgarawany G
Environ Sci Pollut Res Int
. 2020 Apr;
27(16):20014-20024.
PMID: 32236804
Monosodium glutamate (MSG) is widely used as food additive and flavor enhancer; however, consumption of high dose of MSG provokes oxidative stress in many organs and its safety and side...
5.
Tayel S, Saleh A, El-Hefnawy S, Elzorkany K, Elgarawany G, Noreldin R
Curr Mol Med
. 2019 Oct;
20(5):361-371.
PMID: 31629394
Background And Objective: Diabetic nephropathy (DN) is a major determinant of end-stage renal disease (ESRD). Altered microRNA levels lead to serious chronic diseases, such as diabetes. We aimed to measure...